Spotlight on Atomoxetine in Adults with Attention-Deficit Hyperactivity Disorder

By Simpson D.   Plosker G.L.  

CNS Drugs, Vol. 18, Iss. 6, 2004-01 ,pp. : 397-401

Adis International

Access to resources Recommend Favorite

Atomoxetine: A Review of its Use in Attention-Deficit Hyperactivity Disorder in Children and Adolescents

By Garnock-Jones Karly P.   Keating Gillian M.  

Pediatric Drugs, Vol. 11, Iss. 3, 2009-05 ,pp. : 203-226

Adis International

Access to resources Recommend Favorite

Lower IQ is Associated with Decreased Clinical Response to Atomoxetine in Children and Adolescents with Attention-Deficit Hyperactivity Disorder

By Mazzone Luigi  

CNS Drugs, Vol. 25, Iss. 6, 2011-06 ,pp. : 503-509

Adis International

Access to resources Recommend Favorite

Spotlight on Methylphenidate Controlled-Delivery Capsules (Equasym™XL, Metadate CD™) in the Treatment of Children and Adolescents with Attention-Deficit Hyperactivity Disorder

By Anderson Vanessa R.   Keating Gillian M.  

CNS Drugs, Vol. 21, Iss. 2, 2007-01 ,pp. : 173-175

Adis International

Access to resources Recommend Favorite

Switching from Neurostimulant Therapy to Atomoxetine in Children and Adolescents with Attention-Deficit Hyperactivity Disorder: Clinical Approaches and Review of Current Available Evidence

By Prasad Suyash  

Pediatric Drugs, Vol. 10, Iss. 1, 2008-01 ,pp. : 39-47

Adis International

Access to resources Recommend Favorite